Skip to content
ROCHEROCHEROCHESQV 500SQV 500SQV 500

Drawing based on the label description. No photo yet.

“INVIRASE 500-mg film-coated tablets are light orange to greyish- or brownish-orange, oval cylindrical, biconvex tablets with ROCHE and SQV 500 imprinted on the tablet face”

ROCHE SQV 500 pill

Pill with imprint ROCHE SQV 500 is orange, oval, 18 mm and has been identified as Saquinavir Mesylate 500 mg. It is used for HIV. It is supplied by State of Florida Doh Central Pharmacy.

Saquinavir Mesylate 500 mg

Imprint
ROCHE SQV 500
Strength
500 mg
Used for
HIV
Color
Orange
Shape
Oval
Size
18 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
State of Florida Doh Central Pharmacy
Drug class
Antiviral (protease inhibitor)
NDC
53808-0674, 0004-0244, 53808-0674-1

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Saquinavir Mesylate pills and guides

What is Saquinavir Mesylate used for?

Saquinavir Mesylate is used for HIV.

Medicine type
Antiviral (protease inhibitor)
Official uses from the US prescribing label

INVIRASE in combination with ritonavir and other antiretroviral agents is indicated for the treatment of HIV infection. The twice daily administration of INVIRASE in combination with ritonavir is supported by safety data from the MaxCmin 1 study (see Table 6 ) and pharmacokinetic data (see Table 1 ). The efficacy of INVIRASE with ritonavir has not been compared against the efficacy of antiretroviral regimens currently considered standard of care.

Description of Clinical Studies

In a randomized, double-blind clinical study (NV14256) in zidovudine-experienced, HIV-infected patients, INVIRASE in combination with zalcitabine was shown to be superior to either INVIRASE or zalcitabine monotherapy in decreasing the cumulative incidence of clinical disease progression to AIDS-defining events or death. Furthermore, in a randomized study (ACTG229/NV14255), patients with advanced HIV infection with history of prolonged zidovudine treatment and who were given INVIRASE 600 mg (three times daily) + zidovudine + zalcitabine experienced greater increases in CD4 cell counts as compared to those who received INVIRASE + zidovudine or zalcitabine + zidovudine. It should be noted that HIV treatment regimens that were used in these initial clinical studies of INVIRASE are no longer considered standard of care.

Saquinavir gel capsule 1000 mg twice daily coadministered with ritonavir 100 mg twice daily was studied in a heterogeneous population of 148 HIV-infected patients (MaxCmin 1 study). At baseline 42 were treatment naïve and 106 were treatment experienced (of which 52 had an HIV RNA level <400 copies/mL at baseline). Results showed that 91/148 (61%) subjects achieved and/or sustained an HIV RNA level <400 copies/mL at the completion of 48 weeks.

From the FDA-approved label on DailyMed (published Sep 22, 2010).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows ROCHE SQV 500. The parts can be split between the two sides, so turn the pill over and check both.
  • It is orange, oval, 18 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Invirase.

Ingredients

Active: Saquinavir Mesylate

Inactive: Lactose, Povidone K30, Croscarmellose Sodium, Magnesium Stearate, Hypromellose, Titanium Dioxide, Talc, Ferric Oxide Red, Triacetin

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.